Home > Income Statement > NGL FINECHEM

NGL FINECHEM
Revenue

    Back to Income Statement
NGL FINECHEM is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for NGL FINECHEM
Please provide your vote to see the results

NGL FINECHEM Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹339 Cr₹278 Cr₹318 Cr₹258 Cr₹15,168,639 Cr

What is the latest Revenue of NGL FINECHEM ?

The latest Revenue ratio of NGL FINECHEM is ₹339 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹339 Cr
Mar2024₹278 Cr
Mar2023₹318 Cr
Mar2022₹258 Cr
Mar2021₹15,168,639 Cr

How is Revenue of NGL FINECHEM Trending?

Years Revenue % Change
Mar2025 ₹339 Cr
21.79
Mar2024 ₹278 Cr
-12.42
Mar2023 ₹318 Cr
23.08
Mar2022 ₹258 Cr
-100.00
Mar2021 ₹15,168,639 Cr -

Compare Revenue of peers of NGL FINECHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NGL FINECHEM ₹936.2 Cr -0.9% 15.6% -5.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹391,488.0 Cr -2.5% -7% -8% Stock Analytics
DIVIS LABORATORIES ₹159,415.0 Cr -2.2% -7.2% 1.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹132,906.0 Cr -4% 2.8% 27.1% Stock Analytics
CIPLA ₹106,210.0 Cr -5.5% -12.4% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹103,089.0 Cr 5.9% -3.7% -6.5% Stock Analytics


NGL FINECHEM Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NGL FINECHEM

-0.9%

15.6%

-5.9%

SENSEX

-2.4%

-4.7%

6.4%


You may also like the below Video Courses